tirzepatide compounded with niacinamide We are pleased to announce that we are expanding our Weight Management and Longevity offerings. Consider the / Injection in 4mL, a GIP and GLP-1 Receptor Agonist, for a variety Tirzepatide — Peptide Therapy Online

Endocrinology 154(10):36433651

Concordia Pharmaceuticals, Inc

It is an oil soluble, odorless, colorless powder that works well in fragrance-free formulas

A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

For example, high-intensity cycling training significantly increases plasma GLP-1 concentrations in obese individuals, thereby contributing to weight loss (Q et al., 1985)